MedTrace Logo

Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)

NCT00724191 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2020-05-11

No results posted yet for this study

Summary

The purpose of this study is to determine if new MRI methods that measure various information and chemical makeup in the brain, will give early information regarding response to treatment in patients with brain tumors.

Conditions

Interventions

PROCEDURE

MRI

New MRI methods which measure information related to water, blood, and chemical makeup in the brain.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Michigan

    lead OTHER

Principal Investigators

  • Thomas L. Chenevert, Ph.D · University of Michigan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-09-30
Primary Completion
2014-01-15
Completion
2014-01-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00724191 on ClinicalTrials.gov